老板办公室乳摸GIF动态图,色婷婷亚洲一区二区三区,国产全是老熟女太爽了,欧美极度残忍变态另类电影
<strike id="6ck4c"><s id="6ck4c"></s></strike>
<strike id="6ck4c"><s id="6ck4c"></s></strike>
<kbd id="6ck4c"><center id="6ck4c"></center></kbd>
<tr id="6ck4c"><s id="6ck4c"></s></tr>
<tr id="6ck4c"><rt id="6ck4c"></rt></tr>
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.03.01
第四屆董事會第二十次會議決議公告
2019.03.01
第四屆監(jiān)事會第十五次會議決議公告
2019.03.01
關(guān)于繼續(xù)申請內(nèi)保外貸暨為全資子公司提供反擔(dān)保的公告
2019.03.01
關(guān)于使用自有資金購買低風(fēng)險理財產(chǎn)品的公告
2019.02.28
2018年度業(yè)績快報
2019.02.02
關(guān)于第三期員工持股計劃完成股票購買的公告
2019.01.29
關(guān)于第三期員工持股計劃的進(jìn)展公告
2019.01.26
關(guān)于向合格投資者公開發(fā)行公司債券獲得中國證券監(jiān)督管理委員會核準(zhǔn)批復(fù)的公告
2019.01.18
關(guān)于控股子公司股權(quán)架構(gòu)調(diào)整及對外融資的進(jìn)展公告
2019.01.05
對控股子公司增資的進(jìn)展公告
第一頁
上一頁
50
51
52
53
54
下一頁
最后一頁
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
